Moreover, GLP-1-SSM treatment reduced the expression of the pro-inflammatory cytokine IL-1β and inhibited the decline in the chloride anion exchanger DRA, which plays an important role in mitigating IBD-associated diarrhea (Table 1). This evidence concerns the gene GCG and inflammatory bowel disease.